1. Home
  2. COMM vs PHVS Comparison

COMM vs PHVS Comparison

Compare COMM & PHVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CommScope Holding Company Inc.

COMM

CommScope Holding Company Inc.

N/A

Current Price

$17.95

Market Cap

4.2B

Sector

Technology

ML Signal

N/A

Logo Pharvaris N.V.

PHVS

Pharvaris N.V.

N/A

Current Price

$24.23

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
COMM
PHVS
Founded
1976
2015
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
1.7B
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
COMM
PHVS
Price
$17.95
$24.23
Analyst Decision
Hold
Buy
Analyst Count
5
9
Target Price
$13.25
$39.44
AVG Volume (30 Days)
4.7M
534.0K
Earning Date
10-30-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
3.52
N/A
Revenue
$5,299,100,000.00
N/A
Revenue This Year
$37.00
N/A
Revenue Next Year
$7.36
N/A
P/E Ratio
$5.21
N/A
Revenue Growth
33.82
N/A
52 Week Low
$2.94
$11.51
52 Week High
$20.55
$29.80

Technical Indicators

Market Signals
Indicator
COMM
PHVS
Relative Strength Index (RSI) 45.29 48.08
Support Level $18.51 $23.61
Resistance Level $20.61 $24.63
Average True Range (ATR) 0.74 1.94
MACD -0.24 -0.32
Stochastic Oscillator 5.67 16.47

Price Performance

Historical Comparison
COMM
PHVS

About COMM CommScope Holding Company Inc.

CommScope Holding Co Inc is a provider of infrastructure solutions for communication, data center, and entertainment networks. The company provides solutions for wired and wireless networks to enable service providers, including cable, telephone, data center, and digital broadcast satellite operators and media programmers, to deliver media, voice, Internet Protocol (IP) data services, and Wi-Fi to their subscribers and allow enterprises to experience constant wireless and wired connectivity across complex and varied networking environments. The company's operating segments are: Connectivity and Cable Solutions (CCS), Networking, Intelligent Cellular and Security Solutions (NICS), and Access Network Solutions (ANS).

About PHVS Pharvaris N.V.

Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.

Share on Social Networks: